Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Mylan Unit Gets FDA Approval For First Generic Version Of Lescol Capsules

RELATED NEWS
Trade MYL now with 

Mylan Inc.'s (MYL: Quote) subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application or ANDA for Fluvastatin Capsules USP, 20 mg and 40 mg, the first generic version of Novartis' Lescol Capsules. This product is indicated for the treatment of both familial and nonfamilial hypercholesterolemia and mixed dyslipidemia. It is also indicated for the secondary prevention of cardiovascular disease.

According to a settlement and license deal with Novartis, Mylan was granted a license permitting launch prior to the expiration of the pediatric exclusivity associated with U.S. Patent No. 5,356,896, which expires on June 12, 2012. Lescol Capsules had U.S. sales of nearly $27.9 million for the year ending December 31, 2011, according to IMS Health. Mylan has begun shipping its generic version of this product.

Click here to receive FREE breaking news email alerts for Mylan Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Initial jobless claims in the U.S. fell by slightly more than expected in the week ended August 16th, according to a report released by the Labor Department on Thursday. The Labor Department said jobless claims dropped to 298,000, a decrease of 14,000 from the previous week's revised level of 312,000. After ending the previous session mostly higher, stocks may see some further upside in early trading on Thursday. The major index futures are currently pointing to a higher open for the markets, with the Dow futures up by 36 points. U.K. retail sales growth eased in July as auto fuel turnover declined markedly from June, official data showed Thursday. The public sector finance figures were also weaker than expected in July despite economic rebound. Including auto fuel, retail sales volume grew 0.1 percent in July from a month ago, slower than the revised 0.2 percent increase in June, the Office for National Statistics said.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.